XXXIII Congreso Nacional de la Sociedad Española de Trombosis y Hemostasia

XXXIII Congreso Nacional de la Sociedad Española de Trombosis y Hemostasia 58 Lugano classification. J Clin Oncol 2014;32(27):3059-68. 7. Cheson BD. Role of functional imaging in the management of lym- phoma. J Clin Oncol 2011;29(14):1844-54. 8. El-Galaly TC, d’Amore F, Mylam KJ, de Nully Brown P, Bøgsted M, Bukh A, et al. Routine bone marrow biopsy has little or no ther- apeutic consequence for positron emission tomography/computed tomography-staged treatment-naivepatients with Hodgkin lympho- ma. J Clin Oncol 2012;30(36):4508-14. 9. Adams HJ, Kwee TC, de Keizer B, Fijnheer R, de Klerk JM, Littooij AS, et al. Systematic review and meta-analysis on the diagnostic per- formance of FDG-PET/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy still necessary? Ann Oncol 2014:25(5):921-7. 10. Hamilton R, Andrews I, McKay P, Leach M. Loss of utility of bone marrow biopsy as a staging evaluation for Hodgkin lymphoma in the positron emission tomography-computed tomography era: a West of Scotland study. Leuk Lymphoma 2014;55(5):1049-52. 11. Khan AB, Barrington SF, Mikhaeel NG, et al. PET-CT staging of DLBCL accurately dentifies and provides new insight into the clinical significance of bone marrow involvement. In: Blood 2013(122);2013:61-7. DOI: 10.1182/blood-2012-12-473389. 12. Cerci JJ, Györke T, Fanti S, et al. Combined PET and biopsy evi- dence of marrow involvement improves prognostic prediction in diffuse large B-cell lymphoma. J Nucl Med 2014;55(10):1591-7. DOI: 10.2967/jnumed.113.134486. 13. Berthet L, Cochet A, Kanoun S, et al. In Newly Diagnosed Diffuse Large B-Cell Lymphoma, Determination of Bone Marrow Involve- ment with 18F-FDG PET/CT Provides Better Diagnostic Perfor- mance and Prognostic Stratification Than Does Biopsy. J Nucl Med 2013;54(8):1-7. DOI: 10.2967/jnumed.112.114710. 14. Alzahrani M, El-Galaly TC, Hutchings M, et al. The value of rou- tine bone marrow biopsy in patients with diffuse large B-cell lym- phoma staged with PET/CT: A Danish-Canadian study. Ann Oncol 2016;27(6):1095-9. DOI: 10.1093/annonc/mdw137 15. Chen-Liang TH, Martin-Santos T, Jerez A, et al. The role of bone marrow biopsy and FDG-PET/CT in identifying bone marrow infil- tration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. Accuracy in a multicenter series of 372 patients. Am J Hematol 2015;90(8):686-90. 16. Chen-Liang TH, Martin-Santos T, Jerez A, et al. Bone marrow biopsy superiority over PET/CT in predicting progression-free survival in a homogeneously-treated cohort of diffuse large B-cell lymphoma. Cancer Medicine 2017 DOI: 10.1002/cam4.1205. [Epub ahead of print]. 17. Avigdor A. Staging DLBCL: Bone marrow biopsy or PET-CT? Blood 2013;122(1):4-5. 18. Adams HJA, Kwee TC, De Keizer B, Fijnheer R, De Klerk JMH, Nievelstein RAJ. FDG PET/CT for the detection of bone marrow involvement in diffuse large B-cell lymphoma: Systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 2014;41(3):565-74. 19. Pelosi E, Penna D, Douroukas A, et al. Bone marrow disease detec- tion with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study. Q J Nucl Med Mol Imaging 2010:1-7. 20. Hong J, Lee Y, Park Y, et al. Role of FDG-PET/CT in detecting lym- phomatous bone marrow involvement in patients with newly diagnosed diffuse large B-cell lymphoma. Ann Hematol 2012;91(5):687-95. 21. Ujjani CS, Hill EM, Wang H, et al. F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphoma. Br J Haematol 2016;174(3):410-6. 22. Adams HJ, Kwee TC, Fijnheer R, Dubois SV, Nievelstein RA, de Klerk JM. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma. Am J Hematol 2014;89(7):726-31. DOI: 10.1002/ajh.23730. 23. Adams HJA, Kwee TC. Overestimated Value of Baseline Total Metabolic Tumor Volume at 18F-Labeled Fluorodeoxyglucose Pos- itron Emission Tomography in Follicular Lymphoma. J Clin Oncol 2017;35(8):918-9. 24. Ujjani CS, Cheson BD. Overestimated value of FDG-PET based bone marrow evaluation in lymphoma: Response to Adams and Kwee. Br J Haematol 2016. DOI: 10.1111/bjh.14216 [Epub ahead of print]. 25. Adams HJA, Kwee TC. Seriously overestimated prognostic value of baseline and interim FDG-PET in diffuse large B cell lymphoma. Ann Hematol 2016;95(8):1367-8. 26. Adams HJA, Kwee TC. The Need for PrudenceWhen Using 18F-FDG PET as a Reference Standard for Lymphoma Detection. J Nucl Med 2017;58(8):1354-1355. DOI: 10.2967/jnumed.116.187096. 27. Adams HJA, Kwee TC. Increased bone marrow FDG uptake at PET/ CT is not a sufficient proof of bone marrow involvement in diffuse large B-cell lymphoma. Am J Hematol 2015;90(9):182-3.